Stock Analysis Archives - Fairmont Equities

Is Healius a health care stock worth buying?

November 13, 2019November 13, 2019 by Michael Gable

Shares in Healius (ASX:HLS) already seem to pricing in hopes of future earnings upside. With the AGM coming up later this month, could it become a buying opportunity? Or is this one health care stock to stay away from? About Healius Healius, formerly Primary Health Care (ASX:PRY) has three core businesses in pathology, medical centres, and imaging. It also has three emerging businesses in dental, IVF, and day hospitals. The Pathology division accounts for around 54% of overall earnings. It …

Is the McMillan Shakespeare share price at risk?

November 7, 2019 by Michael Gable

The share price for McMillan Shakespeare (ASX:MMS) has done well in the last few months. However, investors should be cautious on chasing it up here. Here is a brief analysis from a fundamental and technical perspective. About McMillan Shakespeare McMillan Shakespeare is a market-leading provider of salary packaging, novated leasing, asset management and related financial products and services. The Company reports across three segments: Group Remuneration Services (GRS), Asset Management and Retail Financial Services (RFS). The GRS segment, whose primary …

The factors underpinning a recovery in Monadelphous

October 31, 2019 by Michael Gable

Monadelphous Group (MND) shares have retraced from a recent high of around $18.00 following the release of disappointing full-year results to 30 June 2019 (FY19). On closer inspection of the fundamentals and outlook, we consider that there are a number of factors that could potentially underpin a recovery. The catalyst for this recovery would be what upcoming AGM on 19 November. About Monadelphous The Company provides construction, maintenance and industrial services to the resources, energy and infrastructure sectors. It operates …

Analysing Steadfast as an investment opportunity

October 24, 2019 by Michael Gable

Following the release of full-year results to 30 June 2019 (FY19) and a pullback in the share price, we analyse the fundamentals and technicals of Steadfast Group (ASX:SDF). About Steadfast Group Steadfast Group has the largest general insurer broker network in Australia, with a market share of ~30%. It also has a small footprint in NZ and Asia. The Company has a stable network of brokers that has grown as new brokers have joined the group. This is either individually …

The waters are still cloudy for Tassal Group

October 17, 2019 by Michael Gable

Tassal Group (ASX:TGR) shares have experienced ongoing weakness since the release of the Company’s FY19 result. Prior to that though the share price had performed fairly consistently. However, planned expansion into the higher-risk prawn category, yet another equity raising and challenges in the salmon business have all been factors that have clouded the operational outlook. With this in mind, we recently reviewed the stock to see the extent to which these concerns, while valid, may be overblown. About Tassal Group …